Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration

Phase 1 Unknown 6 enrolled Sakakibara Heart Institute CellBank of Japan · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and effectiveness of intracoronary infusion of autologous cardiac stem cells in patients with ischemic cardiomyopathy.

Timeline

Start: 2017-11-15
Primary completion: 2022-03
Completion: 2022-03

Publications

Background Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, Pappas P, Tatooles A, Stoddard MF, Lima JA, Slaughter MS, Anversa P, Bolli R. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation. 2012 Sep 11;126(11 Suppl 1):S54-64. doi: 10.1161/CIRCULATIONAHA.112.092627.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Stem cells administered to participants	Unknown	1e+06 cells	Intrathecal

Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration

Summary

Timeline

Publications

Drugs

Indications